New Antibodies to Phospho Alpha Synuclein and Tau

Phospho Alpha Synuclein Antibodies

90% of the alpha-synuclein in Lewy bodies is phosphorylated at serine 129, which makes it a useful method for detecting disease pathology. The phosphorylation of serine 129 may also be related to the aggregation and toxicity of α-synuclein. neuroS provides monoclonal and polyclonal phosphorylated antibodies against pSer129α synuclein.

Phospho Tau Antibodies

Tau hyperphosphorylation precedes tau accumulation in tau accumulation (such as Alzheimer's disease), and may occur at multiple phosphorylation sites. Of particular interest is the phosphorylation at serine 202 and threonine 205, which induces turn-like structures and drives tau aggregation. neuroS provides monoclonal and polyclonal phosphorylated antibodies against phosphorylated Tau.

• iNeuMab™ Mouse Anti-Tau Monoclonal Antibody (CBP2019) [CAT#: NAB2007FY658]
• iNeuMab™ Mouse Anti-Tau Monoclonal Antibody (CBP2020) [CAT#: NAB2007FY659]

Antibodies have been generated against active full length (2N4R) tau pre-formed fibrils (PFFs). NAB2007FY658 detects fibrils more strongly than monomers, and NAB2007FY659 detects both.